Questions around soy isoflavones

1. Writing Group for Women´s Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women´s Health Initiative randomized controlled trial. JAMA 2002; 288(3): 321–333.

2. Rossow JE, Prentice RL, Manson JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and

years since menopause. JAMA 2007; 297(13): 1465–1477.

3. Parkin DM. Cancers of the breast, endometrium and ovary: geographic correlations. Eur J Cancer Clin Oncol 1989; 25(12): 1917–1925.

4. Birkhauser MH, Panay N, Archer DF et al. Updated recommendations for hormone replacement therapy in the peri- and postmenopause. Climacteric 2008; 11(2): 108–124.

5. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, Lippincott Williams Wilkins, 7th edition, Philadelphia 2005. 1333.

6. Donát J. Fytoestrogeny – rostlinné hormony v klimakteriu. Praha: DoMeNa 2006: 110.

7. Duncan AM, Phipps WR, Kurzer MS. Phytoestrogens. Best Practice Research Clin Endocrin Metab 2003; 17(2): 253–271.

8. Ye YB, Tang XY, Verbruggen M et al. Soy isoflavones attenuate bone loss in early postmenopausal Chinese women. Eur J Nutr 2006; 45(6): 327–334.

9. Slíva J. Sójové isoflavony v nevšedních souvislostech. Klimakterická medicína 2010; 15(1): 13–17.

10. Yuan JP, Wang JH, Liu X. Metabolism of dietary soy isoflavones to equol by human instestinal microflora. Mol Nutr Food Res 2007; 51(7): 765–781.

11. Atkinson C, Newton KM, Bowless EJ et al. Demographic, anthropometric, and lifestylefactors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in USA. Am J Clin Nutr 2008; 87(3): 679–687.

12. Raimondi S, Roncaglia L, De Lucia M et al. Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl Microbiol Biotechnol 2009; 81(5): 943–950.

13. Unfer V, Casini ML, Costabile MD et al. Endometrial effects of long-term treatment with phytoestrogens. Fertil Steril 2004; 82(1): 145–148.14. Palacios S, Pornel B, Bergeon C et al. Endometrial safety assessment of a specific andstandardized soy extract according to internationl guidelines. Menopause2007; 14(6): 1006–1011.

15. Ju YH, Allred CD, Allred KF et al. Physiological concentration of dietary genistein dose- dependently stimulate growth of estrogendependent human breast cancer tumors implanted in athymic nude mice. J Nutr 2001; 131(11): 2957–2962.

16. Wuttke W, Jarry H, Becker T et al. Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Maturitas 2008; 61(1–2): 159–170.

17. Teschke R. Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. Menopause 2010; 17(2): 426–440.